Explore detailed financial insights for NSE: Tarsons Products Limited, including share price, quarterly results, governance, and stock forecasts for 2025.

NSE: Tarsons Products Limited Share Price Today, Share Analysis, Latest Updates & Insights | Fincept

Stay informed with the latest announcements for Tarsons, including updates on board meetings and corporate actions.

TARSONS
Tarsons Products Limited - https://www.tarsons.com
Tarsons Products Limited manufactures and trades in scientific plastic labware products in India and internationally. The company offers bottles and carboys; boxes and racks; cell scrappers, plant tissue culture containers, tissue culture flasks, and tissue culture petridish and plates; centrifuge bottles and tubes, caps, and screw caps; mini coolers and card board cyro boxes; cyro aprons, boxes, box racks and canes, cube boxes, gloves, vials, coders, and ice buckets and trays; freezer drawer racks, vertical freezer racks, and vertical racks for chest freezers; and staining boxes, electrophoresis power supply units, gel caster for submarine electrophoresis units, gel scoops, midi submarine electrophoresis units, mini dual vertical electrophoresis units, and mini submarine electrophoresis units. It also provides general lab ware products; instruments; liquid handling; coplin jars, incubation trays, microscopic slide files and trays, petridish, vials, sample containers, Slide Box For Micro Scopes, Slide Dispensers and mailers, slide staining kits, and specimen tubes; plate seals and caps, low profile tube strips, and PCR tubes; and autoclavable bags, biohazardous waste containers, bench protectors, cyro babies/tags, cylindrical tank with covers, elbow connectors, forceps, glove dispensers, hand protector grips, high temperature indicator tapes, spreader steriles, markers, measuring scoops, micro pestle, multi tape dispensers, labelling tapes, n95 particulate respirators, parafilm dispensers, petri seals, pinch clamps, quick disconnect fittings, safety eyewear boxes and face shields, safety googles, sample bags, sharp containers, snapper clamps, soft loop sterile, connectors, tough tags, tubings, and wall mount holders. Its products are used in molecular biology, cell culture, genomics, proteomics, and immunology. Tarsons Products Limited was incorporated in 1983 and is headquartered in Kolkata, India.

Tarsons Products Limited Share Price Today

363.85
OPEN
373.15
HIGH
360.20
LOW
364.55
CLOSE
26 K
VOLUME
2,113 Cr
Market Cap
50493
Average Volume
Healthcare
Sector
NSI
Exchange

Tarsons Products Limited Share Analysis & 2025 Insights

// -->

Investor Presentations

Date Description Download
SIP
Lumpsum
₹25,000
12%
10 Yr

Invested Amount: ₹

Estimated Returns: ₹

Total Value: ₹

NSE: TARSONS Stock Actions

Company
Symbol
ISIN
Subject
Ex Date
Face Value
Broadcast Date
Tarsons Products Limited
TARSONS
INE144Z01023
Annual General Meeting/Dividend - Rs 2 Per Share
20 Sep 2024
2
N/A
Tarsons Products Limited
TARSONS
INE144Z01023
Annual General Meeting
07 Jul 2023
2
N/A
Tarsons Products Limited
TARSONS
INE144Z01023
Annual General Meeting
21 Jul 2022
2
N/A

NSE: TARSONS Recent Announcements

Symbol
Date
Description
Industry
TARSONS
28 Dec 2024, 12:35:05
Spurt in Volume
N/A
TARSONS
27 Dec 2024, 18:17:50
Spurt in Volume
N/A
TARSONS
23 Dec 2024, 15:11:43
Trading Window-XBRL
N/A
TARSONS
23 Dec 2024, 15:09:31
Trading Window
N/A
TARSONS
29 Nov 2024, 13:33:04
Analysts/Institutional Investor Meet/Con. Call Updates
N/A

NSE: TARSONS Corporate Governance

Name
Symbol
Timestamp
Submission Date
XBRL Document
Tarsons Products Limited
TARSONS
18 Oct 2024, 15:56:00
18 Oct 2024, 15:56:00
Tarsons Products Limited
TARSONS
13 Jul 2024, 13:50:00
13 Jul 2024, 13:50:00
Tarsons Products Limited
TARSONS
07 Feb 2024, 13:45:00
07 Feb 2024, 14:15:00
Tarsons Products Limited
TARSONS
14 Oct 2023, 13:46:00
14 Oct 2023, 14:15:00
Tarsons Products Limited
TARSONS
11 Jul 2023, 18:46:00
11 Jul 2023, 19:15:00

NSE: TARSONS Detailed Governance

Category
Date of Birth
Date of Initial Appointment
DIN
Director Name
Status
Chairperson Related To Promoters,Executive Director-MD
03 Feb 1961
25 Jul 1983
00787232
SANJIVE SEHGAL
Active
Executive Director
14 Aug 1988
01 Sep 2014
06963013
ARYAN SEHGAL
Active
Independent Director
17 Aug 1956
20 Nov 2018
00524892
VIRESH OBERAI
Active
Independent Director
28 Oct 1975
10 May 2021
06921540
SUCHARITA BASU DE
Active
Independent Director
10 Apr 1972
10 May 2021
07376482
GIRISH PAMAN VANVARI
Active

NSE: TARSONS Board Meetings

Purpose
Symbol
Industry
ISIN
Name
Time
Board Meeting Intimation
TARSONS
N/A
INE144Z01023
Tarsons Products Limited
28 Oct 2024, 17:35:52
Financial Results
TARSONS
N/A
INE144Z01023
Tarsons Products Limited
08 Aug 2024, 16:49:16
TARSONS PRODUCTS LIMITED has informed the Exchange about Board Meeting to be held on 30-May-2024 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2024 and Dividend/Other business.
TARSONS
N/A
INE144Z01023
Tarsons Products Limited
24 May 2024, 14:15:59
TARSONS PRODUCTS LIMITED has informed the Exchange about Board Meeting to be held on 13-Feb-2024 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended December 2023 and Other business.
TARSONS
N/A
INE144Z01023
Tarsons Products Limited
30 Jan 2024, 16:48:09
Financial Results/Other business matters
TARSONS
N/A
INE144Z01023
Tarsons Products Limited
31 Oct 2023, 17:49:02

NSE: TARSONS Event Calendar

Purpose
Symbol
Industry
ISIN
Name
Time
Description
Financial Results
TARSONS
-
INE144Z01023
Tarsons Products Limited
28 Oct 2024, 00:00:00
To consider and approve the financial results for the period ended September 30, 2024
Financial Results
TARSONS
-
INE144Z01023
Tarsons Products Limited
08 Aug 2024, 00:00:00
To consider and approve the financial results for the period ended Jun 30, 2024
Financial Results/Dividend
TARSONS
-
INE144Z01023
Tarsons Products Limited
24 May 2024, 00:00:00
To consider and approve the financial results for the period ended March 31, 2024 and dividend
Financial Results/Other business matters
TARSONS
-
INE144Z01023
Tarsons Products Limited
30 Jan 2024, 00:00:00
To consider and approve the financial results for the period ended December 31, 2023 and other business matters
Financial Results/Other business matters
TARSONS
-
INE144Z01023
Tarsons Products Limited
31 Oct 2023, 00:00:00
To consider and approve the financial results for the period ended September 30, 2023 and other business matters

NSE: TARSONS Balance Sheet Data In (Cr)

date period_type Ordinary Shares Number Share Issued Net Debt Total Debt Tangible Book Value Invested Capital Working Capital Net Tangible Assets Capital Lease Obligations Common Stock Equity Total Capitalization Total Equity Gross Minority Interest Stockholders Equity Other Equity Interest Retained Earnings Additional Paid In Capital Capital Stock Common Stock Total Liabilities Net Minority Interest Total Non Current Liabilities Net Minority Interest Other Non Current Liabilities Tradeand Other Payables Non Current Non Current Deferred Revenue Non Current Deferred Taxes Liabilities Long Term Debt And Capital Lease Obligation Long Term Capital Lease Obligation Long Term Debt Long Term Provisions Current Liabilities Other Current Liabilities Current Deferred Taxes Liabilities Current Debt And Capital Lease Obligation Current Capital Lease Obligation Current Debt Pensionand Other Post Retirement Benefit Plans Current Current Provisions Payables Other Payable Total Tax Payable Accounts Payable Total Assets Total Non Current Assets Other Non Current Assets Non Current Prepaid Assets Investmentin Financial Assets Available For Sale Securities Goodwill And Other Intangible Assets Other Intangible Assets Goodwill Net PPE Accumulated Depreciation Gross PPE Construction In Progress Other Properties Machinery Furniture Equipment Buildings And Improvements Land And Improvements Properties Current Assets Other Current Assets Restricted Cash Prepaid Assets Inventory Other Inventories Finished Goods Work In Process Raw Materials Other Receivables Accounts Receivable Allowance For Doubtful Accounts Receivable Gross Accounts Receivable Cash Cash Equivalents And Short Term Investments Other Short Term Investments Cash And Cash Equivalents Cash Equivalents Cash Financial
2024-09-30T00:00:00 quarterly 53,206,281.00 53,206,281.00 2,849,080,000.00 3,169,880,000.00 5,470,050,000.00 9,187,780,000.00 427,580,000.00 5,470,050,000.00 121,160,000.00 6,139,060,000.00 7,738,690,000.00 6,139,060,000.00 6,139,060,000.00 6,032,650,000.00 0.00 0.00 106,410,000.00 106,410,000.00 4,403,950,000.00 2,204,270,000.00 405,010,000.00 0.00 0.00 100,170,000.00 1,691,590,000.00 91,960,000.00 1,599,630,000.00 2,430,000.00 2,199,680,000.00 46,080,000.00 0.00 1,478,290,000.00 29,200,000.00 1,449,090,000.00 0.00 24,000,000.00 161,480,000.00 0.00 0.00 161,480,000.00 10,543,010,000.00 7,915,750,000.00 819,650,000.00 0.00 36,580,000.00 36,580,000.00 669,010,000.00 343,760,000.00 325,250,000.00 6,300,700,000.00 0.00 6,300,700,000.00 2,168,050,000.00 4,132,650,000.00 0.00 0.00 0.00 0.00 2,627,260,000.00 171,100,000.00 0.00 0.00 1,393,630,000.00 0.00 0.00 0.00 0.00 0.00 698,500,000.00 0.00 0.00 364,030,000.00 164,390,000.00 199,640,000.00 0.00 0.00
2024-03-31T00:00:00 quarterly 53,206,281.00 53,206,281.00 2,396,720,000.00 2,690,200,000.00 5,437,340,000.00 8,696,440,000.00 221,220,000.00 5,437,340,000.00 122,380,000.00 6,128,620,000.00 7,148,690,000.00 6,128,620,000.00 6,128,620,000.00 6,022,210,000.00 4,546,650,000.00 1,459,170,000.00 106,410,000.00 106,410,000.00 3,593,220,000.00 1,461,670,000.00 245,210,000.00 3,370,000.00 245,210,000.00 92,160,000.00 1,117,590,000.00 97,520,000.00 1,020,070,000.00 1,810,000.00 2,131,550,000.00 40,430,000.00 20,740,000.00 1,572,610,000.00 24,860,000.00 1,547,750,000.00 24,200,000.00 24,200,000.00 482,250,000.00 335,840,000.00 20,740,000.00 146,410,000.00 9,721,840,000.00 7,369,070,000.00 1,251,520,000.00 46,490,000.00 720,000.00 720,000.00 691,280,000.00 366,030,000.00 325,250,000.00 6,588,370,000.00 -1,301,960,000.00 7,890,330,000.00 3,921,750,000.00 1,457,870,000.00 1,604,880,000.00 402,970,000.00 502,860,000.00 0.00 2,352,770,000.00 60,220,000.00 0.00 54,060,000.00 1,287,260,000.00 81,540,000.00 719,210,000.00 124,480,000.00 362,030,000.00 6,480,000.00 778,860,000.00 -4,370,000.00 783,230,000.00 226,110,000.00 55,010,000.00 171,100,000.00 0.00 171,100,000.00
2024-03-31T00:00:00 annual 53,206,281.00 53,206,281.00 2,396,720,000.00 2,690,200,000.00 5,437,340,000.00 8,696,440,000.00 221,220,000.00 5,437,340,000.00 122,380,000.00 6,128,620,000.00 7,148,690,000.00 6,128,620,000.00 6,128,620,000.00 6,022,210,000.00 4,546,650,000.00 1,459,170,000.00 106,410,000.00 106,410,000.00 3,593,220,000.00 1,461,670,000.00 245,210,000.00 3,370,000.00 245,210,000.00 92,160,000.00 1,117,590,000.00 97,520,000.00 1,020,070,000.00 1,810,000.00 2,131,550,000.00 40,430,000.00 20,740,000.00 1,572,610,000.00 24,860,000.00 1,547,750,000.00 24,200,000.00 24,200,000.00 482,250,000.00 335,840,000.00 20,740,000.00 146,410,000.00 9,721,840,000.00 7,369,070,000.00 1,251,520,000.00 46,490,000.00 720,000.00 720,000.00 691,280,000.00 366,030,000.00 325,250,000.00 6,588,370,000.00 -1,301,960,000.00 7,890,330,000.00 3,921,750,000.00 1,457,870,000.00 1,604,880,000.00 402,970,000.00 502,860,000.00 0.00 2,352,770,000.00 60,220,000.00 0.00 54,060,000.00 1,287,260,000.00 81,540,000.00 719,210,000.00 124,480,000.00 362,030,000.00 6,480,000.00 778,860,000.00 -4,370,000.00 783,230,000.00 226,110,000.00 55,010,000.00 171,100,000.00 0.00 171,100,000.00
2023-09-30T00:00:00 quarterly 53,206,281.00 53,206,281.00 991,770,000.00 1,229,370,000.00 5,907,360,000.00 7,140,570,000.00 1,391,810,000.00 5,907,360,000.00 520,000.00 5,911,720,000.00 6,675,590,000.00 5,911,720,000.00 5,911,720,000.00 5,805,310,000.00 0.00 0.00 106,410,000.00 106,410,000.00 1,574,600,000.00 916,900,000.00 90,900,000.00 0.00 0.00 60,710,000.00 764,360,000.00 490,000.00 763,870,000.00 0.00 657,700,000.00 29,720,000.00 0.00 465,010,000.00 30,000.00 464,980,000.00 0.00 18,200,000.00 93,290,000.00 0.00 0.00 93,290,000.00 7,486,320,000.00 5,436,810,000.00 1,279,050,000.00 0.00 39,540,000.00 39,540,000.00 4,360,000.00 0.00 0.00 4,074,590,000.00 0.00 4,074,590,000.00 1,468,840,000.00 2,605,750,000.00 0.00 0.00 0.00 0.00 2,049,510,000.00 92,660,000.00 0.00 0.00 1,183,610,000.00 0.00 0.00 0.00 0.00 0.00 535,840,000.00 0.00 0.00 237,400,000.00 320,000.00 237,080,000.00 0.00 0.00
2023-03-31T00:00:00 quarterly 53,206,281.00 53,206,281.00 515,830,000.00 1,106,920,000.00 5,687,910,000.00 6,799,440,000.00 1,891,180,000.00 5,687,910,000.00 510,000.00 5,693,030,000.00 6,499,940,000.00 5,693,030,000.00 5,693,030,000.00 5,586,620,000.00 4,121,590,000.00 1,459,170,000.00 106,410,000.00 106,410,000.00 1,563,800,000.00 934,650,000.00 72,790,000.00 0.00 72,710,000.00 54,120,000.00 807,390,000.00 480,000.00 806,910,000.00 0.00 629,150,000.00 38,910,000.00 19,290,000.00 299,530,000.00 30,000.00 299,500,000.00 20,100,000.00 20,100,000.00 261,730,000.00 165,260,000.00 19,290,000.00 96,470,000.00 7,256,830,000.00 4,736,500,000.00 1,235,850,000.00 39,840,000.00 40,520,000.00 40,520,000.00 5,120,000.00 5,120,000.00 0.00 4,668,890,000.00 -913,190,000.00 5,582,080,000.00 2,425,520,000.00 1,129,180,000.00 1,287,410,000.00 264,440,000.00 475,530,000.00 0.00 2,520,330,000.00 118,500,000.00 9,090,000.00 111,420,000.00 1,143,730,000.00 56,940,000.00 503,400,000.00 134,750,000.00 448,640,000.00 7,540,000.00 657,970,000.00 0.00 657,970,000.00 590,580,000.00 9,650,000.00 590,580,000.00 531,300,000.00 59,280,000.00
2023-03-31T00:00:00 annual 53,206,281.00 53,206,281.00 515,830,000.00 1,106,920,000.00 5,687,910,000.00 6,799,440,000.00 1,891,180,000.00 5,687,910,000.00 510,000.00 5,693,030,000.00 6,499,940,000.00 5,693,030,000.00 5,693,030,000.00 5,586,620,000.00 4,121,590,000.00 1,459,170,000.00 106,410,000.00 106,410,000.00 1,563,800,000.00 934,650,000.00 72,790,000.00 0.00 72,710,000.00 54,120,000.00 807,390,000.00 480,000.00 806,910,000.00 0.00 629,150,000.00 38,910,000.00 19,290,000.00 299,530,000.00 30,000.00 299,500,000.00 20,100,000.00 20,100,000.00 261,730,000.00 165,260,000.00 19,290,000.00 96,470,000.00 7,256,830,000.00 4,736,500,000.00 1,235,850,000.00 39,840,000.00 40,520,000.00 40,520,000.00 5,120,000.00 5,120,000.00 0.00 4,668,890,000.00 -913,190,000.00 5,582,080,000.00 2,425,520,000.00 1,129,180,000.00 1,287,410,000.00 264,440,000.00 475,530,000.00 0.00 2,520,330,000.00 118,500,000.00 9,090,000.00 111,420,000.00 1,143,730,000.00 56,940,000.00 503,400,000.00 134,750,000.00 448,640,000.00 7,540,000.00 657,970,000.00 0.00 657,970,000.00 590,580,000.00 9,650,000.00 590,580,000.00 531,300,000.00 59,280,000.00
2022-03-31T00:00:00 annual 53,206,281.00 53,206,281.00 0.00 216,650,000.00 4,891,660,000.00 5,114,470,000.00 2,096,110,000.00 4,891,660,000.00 480,000.00 4,898,300,000.00 4,991,750,000.00 4,898,300,000.00 4,898,300,000.00 4,791,890,000.00 3,326,860,000.00 1,459,170,000.00 106,410,000.00 106,410,000.00 543,960,000.00 194,820,000.00 1,030,000.00 0.00 56,320,000.00 43,570,000.00 93,900,000.00 450,000.00 93,450,000.00 0.00 349,140,000.00 46,830,000.00 0.00 122,750,000.00 30,000.00 122,720,000.00 14,920,000.00 14,920,000.00 187,220,000.00 57,700,000.00 0.00 129,520,000.00 5,442,260,000.00 2,997,010,000.00 -1,030,000.00 58,490,000.00 1,030,000.00 1,030,000.00 6,640,000.00 6,640,000.00 0.00 2,906,260,000.00 -637,100,000.00 3,543,360,000.00 1,024,990,000.00 924,450,000.00 863,780,000.00 254,610,000.00 475,530,000.00 0.00 2,445,250,000.00 110,960,000.00 83,770,000.00 92,470,000.00 823,740,000.00 30,870,000.00 477,690,000.00 4,120,000.00 311,060,000.00 19,070,000.00 651,780,000.00 -4,390,000.00 656,170,000.00 774,420,000.00 84,350,000.00 774,420,000.00 687,140,000.00 87,280,000.00
2021-03-31T00:00:00 annual 53,206,281.00 53,206,281.00 311,220,000.00 335,010,000.00 2,437,550,000.00 2,777,920,000.00 710,030,000.00 2,437,550,000.00 470,000.00 2,443,380,000.00 2,476,120,000.00 2,443,380,000.00 2,443,380,000.00 0.00 2,418,120,000.00 17,480,000.00 1,920,000.00 1,920,000.00 516,120,000.00 98,130,000.00 530,000.00 0.00 31,620,000.00 32,800,000.00 33,180,000.00 440,000.00 32,740,000.00 0.00 417,990,000.00 10,000.00 0.00 301,830,000.00 30,000.00 301,800,000.00 15,310,000.00 0.00 94,450,000.00 34,700,000.00 0.00 59,750,000.00 2,959,500,000.00 1,831,480,000.00 -530,000.00 28,200,000.00 530,000.00 530,000.00 5,830,000.00 5,830,000.00 0.00 1,770,680,000.00 -423,810,000.00 2,194,490,000.00 566,380,000.00 587,900,000.00 542,730,000.00 239,440,000.00 258,040,000.00 0.00 1,128,020,000.00 0.00 8,130,000.00 140,180,000.00 466,970,000.00 17,580,000.00 303,400,000.00 7,060,000.00 138,930,000.00 19,050,000.00 470,370,000.00 -1,640,000.00 472,010,000.00 23,320,000.00 0.00 23,320,000.00 130,000.00 23,190,000.00
2020-03-31T00:00:00 annual 0.00 0.00 105,840,000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 10,000.00 9,410,000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

NSE: TARSONS Cash Flow Data In (Cr)

date period_type Free Cash Flow Repurchase Of Capital Stock Repayment Of Debt Issuance Of Debt Issuance Of Capital Stock Capital Expenditure End Cash Position Other Cash Adjustment Outside Changein Cash Beginning Cash Position Effect Of Exchange Rate Changes Changes In Cash Financing Cash Flow Net Other Financing Charges Interest Paid Cff Net Common Stock Issuance Common Stock Payments Common Stock Issuance Net Issuance Payments Of Debt Net Short Term Debt Issuance Short Term Debt Payments Short Term Debt Issuance Net Long Term Debt Issuance Long Term Debt Payments Long Term Debt Issuance Investing Cash Flow Net Other Investing Changes Interest Received Cfi Net Investment Purchase And Sale Sale Of Investment Purchase Of Investment Net Business Purchase And Sale Purchase Of Business Net PPE Purchase And Sale Sale Of PPE Purchase Of PPE Operating Cash Flow Taxes Refund Paid Change In Working Capital Change In Other Current Liabilities Change In Other Current Assets Change In Payable Change In Inventory Change In Receivables Other Non Cash Items Provisionand Write Offof Assets Depreciation And Amortization Amortization Cash Flow Depreciation Net Foreign Currency Exchange Gain Loss Gain Loss On Sale Of PPE Net Income From Continuing Operations
2024-03-31T00:00:00 annual -816,280,000.00 0.00 -827,640,000.00 2,287,250,000.00 0.00 -1,843,330,000.00 171,100,000.00 30,000.00 637,860,000.00 -530,000.00 -466,260,000.00 1,356,250,000.00 0.00 -95,570,000.00 0.00 0.00 0.00 1,459,610,000.00 1,021,770,000.00 -410,210,000.00 1,431,980,000.00 437,840,000.00 -417,430,000.00 855,270,000.00 -2,849,560,000.00 -10,000.00 16,500,000.00 -44,750,000.00 4,250,000.00 -49,000,000.00 -651,350,000.00 -651,350,000.00 -1,840,000,000.00 3,330,000.00 -1,843,330,000.00 1,027,050,000.00 -183,990,000.00 85,790,000.00 26,560,000.00 65,770,000.00 -6,150,000.00 75,150,000.00 -74,130,000.00 65,920,000.00 41,500,000.00 404,030,000.00 13,810,000.00 390,220,000.00 5,460,000.00 660,000.00 607,680,000.00
2023-03-31T00:00:00 annual -1,143,690,000.00 0.00 -249,770,000.00 1,140,660,000.00 0.00 -1,899,680,000.00 590,580,000.00 0.00 774,420,000.00 40,000.00 -183,880,000.00 845,610,000.00 0.00 -45,250,000.00 0.00 0.00 0.00 890,890,000.00 -10,050,000.00 -99,030,000.00 88,980,000.00 900,940,000.00 -150,740,000.00 1,051,680,000.00 -1,785,480,000.00 0.00 33,650,000.00 69,930,000.00 69,930,000.00 0.00 0.00 0.00 -1,889,060,000.00 10,620,000.00 -1,899,680,000.00 755,990,000.00 -243,030,000.00 -363,220,000.00 -14,220,000.00 11,220,000.00 -31,070,000.00 -319,990,000.00 2,250,000.00 3,050,000.00 -4,390,000.00 285,090,000.00 1,520,000.00 283,570,000.00 -6,040,000.00 -2,670,000.00 1,087,200,000.00
2022-03-31T00:00:00 annual -485,020,000.00 0.00 -2,911,500,000.00 2,793,210,000.00 1,497,010,000.00 -1,319,690,000.00 774,420,000.00 260,000.00 23,320,000.00 130,000.00 750,970,000.00 1,295,750,000.00 0.00 -42,590,000.00 1,497,010,000.00 0.00 1,497,010,000.00 -118,290,000.00 -221,470,000.00 -2,581,470,000.00 2,360,000,000.00 103,180,000.00 -330,030,000.00 433,210,000.00 -1,379,450,000.00 0.00 8,550,000.00 -69,300,000.00 1,739,400,000.00 -1,808,700,000.00 0.00 0.00 -1,318,700,000.00 990,000.00 -1,319,690,000.00 834,670,000.00 -333,770,000.00 -418,090,000.00 37,720,000.00 17,400,000.00 59,670,000.00 -357,010,000.00 -178,230,000.00 21,090,000.00 2,820,000.00 219,610,000.00 1,370,000.00 218,240,000.00 -6,460,000.00 -420,000.00 1,349,890,000.00
2021-03-31T00:00:00 annual 38,330,000.00 -219,990,000.00 -1,547,360,000.00 1,544,750,000.00 0.00 -643,220,000.00 23,320,000.00 70,000.00 253,110,000.00 0.00 -229,790,000.00 -272,230,000.00 0.00 -49,610,000.00 -219,990,000.00 -219,990,000.00 0.00 -2,610,000.00 65,050,000.00 -1,414,540,000.00 1,479,590,000.00 -67,660,000.00 -132,820,000.00 65,160,000.00 -639,110,000.00 0.00 2,540,000.00 -20,000.00 626,900,000.00 -626,920,000.00 0.00 0.00 -641,630,000.00 1,590,000.00 -643,220,000.00 681,550,000.00 -240,660,000.00 -159,760,000.00 3,910,000.00 -100,070,000.00 710,000.00 20,310,000.00 -87,430,000.00 22,310,000.00 -280,000.00 136,620,000.00 0.00 136,620,000.00 0.00 -1,020,000.00 924,340,000.00
2020-03-31T00:00:00 annual 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -60,000.00 0.00 0.00 0.00 0.00 -20,000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -40,000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

NSE: TARSONS Income Statement Data In (Cr)

date period_type Tax Effect Of Unusual Items Tax Rate For Calcs Normalized EBITDA Total Unusual Items Total Unusual Items Excluding Goodwill Net Income From Continuing Operation Net Minority Interest Reconciled Depreciation Reconciled Cost Of Revenue EBITDA EBIT Net Interest Income Interest Expense Interest Income Normalized Income Net Income From Continuing And Discontinued Operation Total Expenses Rent Expense Supplemental Diluted Average Shares Basic Average Shares Diluted EPS Basic EPS Diluted NI Availto Com Stockholders Average Dilution Earnings Net Income Common Stockholders Otherunder Preferred Stock Dividend Net Income Net Income Including Noncontrolling Interests Net Income Continuous Operations Tax Provision Pretax Income Other Non Operating Income Expenses Special Income Charges Other Special Charges Net Non Operating Interest Income Expense Total Other Finance Cost Interest Expense Non Operating Interest Income Non Operating Operating Income Operating Expense Other Operating Expenses Depreciation And Amortization In Income Statement Amortization Depreciation Income Statement Selling General And Administration Selling And Marketing Expense General And Administrative Expense Rent And Landing Fees Gross Profit Cost Of Revenue Total Revenue Operating Revenue
2024-03-31T00:00:00 annual -0.02 0.00 111.25 -0.07 -0.07 42.64 40.40 94.29 111.19 70.79 -8.37 10.02 1.78 42.69 42.64 231.39 0.80 5.32 5.32 0.00 0.00 42.64 0.00 42.64 0.00 42.64 42.64 42.64 18.13 60.77 0.21 -0.07 0.07 -8.37 0.13 10.02 1.78 63.35 137.10 34.90 40.40 1.38 39.02 21.96 9.80 12.16 0.80 200.45 94.29 294.74 294.74
2023-03-31T00:00:00 annual 0.07 0.00 141.35 0.27 0.27 80.71 28.51 78.24 141.62 113.11 -1.57 4.39 2.89 80.52 80.71 176.87 0.70 5.32 5.32 0.00 0.00 80.71 0.00 80.71 0.00 80.71 80.71 80.71 28.01 108.72 0.07 0.27 -0.27 -1.57 0.08 4.39 2.89 104.49 98.63 26.72 28.51 0.15 28.36 13.75 10.44 3.32 0.70 203.12 78.24 281.36 281.36
2022-03-31T00:00:00 annual 0.01 0.00 160.88 0.04 0.04 100.66 21.96 80.06 160.93 138.96 -2.90 3.98 1.31 100.63 100.66 165.03 0.39 5.17 5.17 0.00 0.00 100.66 0.00 100.66 0.00 100.66 100.66 100.66 34.33 134.99 0.07 0.04 -0.04 -2.90 0.24 3.98 1.31 134.16 84.97 25.74 21.96 0.14 21.82 10.50 7.83 2.67 0.39 219.13 80.06 299.19 299.19
2021-03-31T00:00:00 annual 0.03 0.00 108.72 0.10 0.10 68.87 13.66 74.28 108.82 95.16 -2.43 2.72 0.29 68.79 68.87 135.53 0.18 5.09 5.09 0.00 0.00 68.87 0.00 68.87 0.00 68.87 68.87 68.87 23.56 92.43 0.28 0.10 -0.10 -2.43 0.00 2.72 0.29 92.38 61.25 18.38 13.66 0.00 13.66 8.20 6.08 2.12 0.18 153.63 74.28 227.91 227.91
2020-03-31T00:00:00 annual 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 2.15 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

FII & DII Data (In Cr)

Date FII Gross Purchase FII Gross Sales FII Net Purchase / Sales DII Gross Purchase DII Gross Sales DII Net Purchase / Sales
2025-02-03 12,505.92 16,464.29 -3,958.37 19,319.48 16,611.25 2,708.23
2025-01-30 10,513.63 15,096.58 -4,582.95 13,934.35 11,768.46 2,165.89
2025-01-29 7,644.40 10,230.83 -2,586.43 12,871.38 11,078.67 1,792.71
2025-01-27 9,488.57 14,504.03 -5,015.46 16,503.43 9,861.28 6,642.15
2025-01-24 11,230.47 13,988.96 -2,758.49 12,835.41 10,433.10 2,402.31
2025-01-23 13,316.55 18,779.07 -5,462.52 14,412.73 10,700.18 3,712.55
2025-01-22 12,936.64 16,962.89 -4,026.25 15,437.18 11,796.96 3,640.22
Quarterly Results
Profit & Loss
Piotroski F-Score
8/9
0 1 2 3 4 5 6 7 8 9

Key Metrics

EPS

6.47

P/E

61.282845

P/B

3.4438431

Dividend Yield

0.5%

Market Cap

2,112.53 Cr.

Face Value

115.133

Book Value

115.133

ROE

9.83%

EBITDA Growth

96.04 Cr.

Debt/Equity

51.635

Short Term

Subscribe to unlock this feature

Medium Term

Subscribe to unlock this feature

Long Term

Subscribe to unlock this feature

Yearly Stock Performance Heatmap

Latest Updates

TARSONS News

Ashoka Buildcon Arm Signs Rs 1,391 Crore Pact With NHAI

Ashoka Buildcon Ltd. announced on Monday, via an exchange filing, that its wholly owned subsidiary, Ashoka Bowaichandi Guskara Road Pvt Ltd., has exec...

Source: www.ndtvprofit.com
Date: 06 Jan 2025, 19:50

TARSONS News

Budget 2025: Rahul Bajoria On Addressing Income Growth And Consumption Trends

"However, discretionary, high-value consumption is taking a step back due to income growth settling at high single digits." Over the past fe...

Source: www.ndtvprofit.com
Date: 06 Jan 2025, 19:47

TARSONS News

FPIs Stay Net Sellers, Sell Stocks Worth Rs 2,575 Crore

Foreign portfolio investors stayed net sellers for the second straight session on Monday and sold stocks worth approximately Rs 2,575.1 crore, accordi...

Source: www.ndtvprofit.com
Date: 06 Jan 2025, 19:37

TARSONS News

Budget 2025: AMFI Seeks Tax Policy Reforms To Drive Mutual Fund Investments In 15-Point Proposal

The Association of Mutual Funds of India on Monday released a 15-point proposal for Union Budget 2025-26 requesting changes in tax policies that are i...

Source: www.ndtvprofit.com
Date: 06 Jan 2025, 19:23

TARSONS News

Apple iPhone SE 4: Price To Features, 11 Things You Need To Know

iPhone 16e (Not iPhone SE 4): If recent reports are to be believed, Apple may discontinue the SE label and rename iPhone SE 4 as iPhone 16e. Most Affo...

Source: www.ndtvprofit.com
Date: 06 Jan 2025, 19:12

TARSONS News

Rupee Closed Weaker Against The US Dollar

The rupee weakened by five paise to close at 85.83 against the US dollar. The Indian rupee had declined to a fresh low against the US dollar during th...

Source: www.ndtvprofit.com
Date: 06 Jan 2025, 15:54

TARSONS News

Table Space Founder Amit Banerji Dies Of Heart Attack At Age Of 45

Amit Banerji, the founder, chairman and chief executive officer of managed workspace provider Table Space, died after suffering from a heart attack, r...

Source: www.ndtvprofit.com
Date: 06 Jan 2025, 19:09

TARSONS News

War Fatigue, Economic Breakdown Or Pro-West? Why Syria's Al-Sharaa Is Seen Soft On Israel

The strategic positions have been used by Israeli forces to carry out hundreds of strikes to destroy Syria's military infrastructure. In 2011, be...

Source: www.ndtvprofit.com
Date: 06 Jan 2025, 19:00

Popular Questions

How to Buy tarsons Shares on Fincept?

You can buy Tarsons Products Limited shares on Different Brokers & Banks by creating an account and completing KYC verification online.

What is the Market Cap of tarsons?

The market capitalization of Tarsons Products Limited is ₹2,113 Cr as of 05 Feb 2025.

What are the PE and PB ratios of Tarsons Products Limited?

The PE and PB ratios of Tarsons Products Limited are Not Available and 3.4438431 respectively as of 05 Feb 2025.

What is the 52 Week High of Tarsons Products Limited?

The 52-week high of Tarsons Products Limited is ₹551.95 as of 05 Feb 2025.

What is the 52 Week Low of Tarsons Products Limited?

The 52-week low of Tarsons Products Limited is ₹378 as of 05 Feb 2025.

What are the earnings per share (EPS) for Tarsons Products Limited?

The Earnings Per Share (EPS) of Tarsons Products Limited is ₹6.47 as per the most recent quarterly results available on Fincept.

What is the ROE (Return on Equity) of Tarsons Products Limited?

The Return on Equity (ROE) of Tarsons Products Limited is 9.83% as per the most recent financial year data. Explore more on Fincept.

MRO-TEK

View Stock

LICHSGFIN

View Stock

FORCEMOT

View Stock

ISGEC

View Stock

SANWARIA

View Stock

VIJIFIN

View Stock

GRASIM

View Stock

SHAREINDIA

View Stock

MAWANASUG

View Stock

SPLIL

View Stock

NITINSPIN

View Stock

TATATECH

View Stock

GROBTEA

View Stock

AETHER

View Stock

SYNGENE

View Stock